Table 4: Summary results for all indirect comparisons following successive steps to build the final comparison of lixisenatide versus insulin neutral protamine Hagedorn in the treatment of type 2 diabetes mellitus
Table 4: Summary results for all indirect comparisons following successive steps to build the final comparison of lixisenatide versus insulin neutral protamine Hagedorn in the treatment of type 2 diabetes mellitus